To include your compound in the COVID-19 Resource Center, submit it here.

Ganaxolone: Phase II data

Top-line data from a double-blind, crossover, U.S. and Belgian Phase II trial in 59 patients ages 6-17 with Fragile X syndrome showed

Read the full 223 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE